Latest "Convoy for a Cure" News Stories

17:32 EST 14th December 2017 | BioPortfolio

Here are the most relevant search results for "Convoy for a Cure" found in our extensive news archives from over 250 global news sources.

More Information about Convoy for a Cure on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Convoy for a Cure for you to read. Along with our medical data and news we also list Convoy for a Cure Clinical Trials, which are updated daily. BioPortfolio also has a large database of Convoy for a Cure Companies for you to search.

Showing "Convoy Cure" News Articles 1–25 of 1,100+

Thursday 14th December 2017

Vitalah® Introduces OXYLENT® Memory with Cognizin® Citicoline for Brain Health Support

Daily supplement launched at recent Natural Products Expo East show NEW YORK (PRWEB) December 14, 2017 Consumers looking to boost brain health, mental clarity and alertness have a new daily supplement to add to nutritional plans: OXYLENT® Memory with Cognizin® Citicoline. OXYLENT® Memory is designed to support natural energy and cognitive function for heightened alertness and focus...

'Mind-blowing' gene therapy could herald a cure for haemophilia, study shows

A team of clinical researchers at Barts Health NHS Trust and Queen Mary University of London have reported that a single gene therapy treatment has proved remarkably effective in the treatment of haemophilia A one year after infusion, with patients displaying normal levels of the missing protein that characterises the condition. read more

Novel Finding on Memory T Cells May Provide Boost to Cancer Immunotherapy

Scientists report that they have shown conclusively that memory T cells responsible for long-term immune protection arise from effector CD8 T cells. The finding provides insight that should help researchers design more effective vaccines and expand cancer immunotherapies by aiding efforts to harness the immune cells to prevent or cure diseases. The study ( “Effector CD8 T cells ded...

‘Mind-blowing’ trial could transform treatment for haemophilia sufferers –'Mind-blowing' trial could transform treatment for haemophilia sufferersBT.comThirteen patients were injected with a copy of a missing gene, which allowed cells to produce the missing factor. Share this. Facebook; Twitter; Google plus; Email; Share. 0. 'Mind-blowing' trial could transform treatment for haemophilia sufferers ...Leap forward towards gene therapy cure for haemophilia AThe Guard...

‘Mind-blowing’ trial could transform treatment for haemophilia sufferers – Belfast Telegraph

Belfast Telegraph'Mind-blowing' trial could transform treatment for haemophilia sufferersBelfast TelegraphThirteen patients were injected with a copy of a missing gene, which allowed cells to produce the missing factor. Jake Omer, 29, who suffers from haemophilia is part of the test group (. 1 1 Jake Omer, 29, who suffers from haemophilia is part of the ...Leap forward towards gene therapy cure fo...

Groundbreaking Gene Therapy Trial Set to Cure Hemophilia

A single infusion of the gene therapy drug showed improved levels of the essential blood clotting protein Factor VIII

Wednesday 13th December 2017

Groundbreaking gene therapy trial brings cure for hemophilia closer

A 'cure' for hemophilia is one step closer, following results of a groundbreaking gene therapy trial led by the NHS in London.

Haemophilia A trial results ‘mind-blowing’ – BBC News

BBC NewsHaemophilia A trial results 'mind-blowing'BBC NewsBritish doctors say they have achieved "mind-blowing" results in an attempt to rid people of haemophilia A. Patients are born with a genetic defect that means they do not produce a protein needed to stop bleeding. Thirteen patients given the gene ...Leap forward towards gene therapy cure for haemophilia AThe GuardianGroundbreaking gene ther...

Simulation model finds Cure Violence program and targeted policing curb urban violence

(University of California - Davis Health System) When communities and police work together to deter urban violence, they can achieve better outcomes with fewer resources than when each works in isolation, a simulation model created by researchers at the UC Davis Violence Prevention Research Program, Columbia University's Mailman School of Public Health and the University at Albany has found.

American Diabetes Association Designates Blue Shield of California as Health Champion

Nonprofit health plan Blue Shield of California has been designated a Health Champion by the American Diabetes Association® (Association) as part of the Association’s Wellness Lives HereTM initiative. This designation recognizes companies and organizations that are committed to improving employee health and inspire and encourage wellness programs in the...

Pure Encapsulations® Nrf2 Detox with Setria® L-Glutathione Now Available

Three-Ingredient Daily Supplement Stimulates Detoxification* New York, NY (PRWEB) December 13, 2017 Provide your body with the support it needs to fight the effects of oxidative stress.* Pure Encapsulations® Nrf2 Detox with Setria® Glutathione is now available in Germany and Austria. Nrf2 Detox is a three-ingredient blend that contains broccoli sprout concentrate—a cruciferous vegetab...

MJH Studios™ Featured in Post Magazine

The article shines the spotlight on MJH Studios™ state-of-the-art production facility. MJH Studios™, a world-class production facility and resource center dedicated to the creation and distribution of original content, was recently featured in Post Magazine. The article highlights the successful growth of the studio and its ability to offer a super...

There’s No HIV Cure Yet, But With Each Promising Case, Scientists Become More Excited

There have been a few unique cases recently that have offered movement forward toward an eventual cure.

North America Radiotherapy MarketAnalysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024 [Report Updated: 01022017] Prices from USD $4200

The North America Radiotherapy Market has accounted for USD 2.2 billion in 2016, and is expected to reach USD 3.5 billion by 2024, it is accounted to grow at a CAGR 5.8% during the forecast period 2017 to 2024.Cancer is the major cause of death in the world and the number of new patients each year is steadily increasing. The most common form of cancer mortality is by metastasis, where the tumors a...

Serving Those Who Served

Bristol-Myers Squibb Foundation has teamed up with the U.S. Department of Veterans Affairs to help improve lung cancer survival rates for veterans SOURCE: Bristol-Myers Squibb Company DESCRIPTION:With the help of the Bristol-Myers Squibb Foundation, the U.S. Department of Veterans Affairs is hoping to wage a war on lung cancer by increasing veterans’ access to lung cancer screenings across the c...

Tuesday 12th December 2017

New Roswell Park Research Suggests Strategy to Unleash Cancer-Fighting Power of p53

A team from Roswell Park Cancer Institute reports their discovery of a major mechanism by which cells regulate the tumor suppressor, opening up new avenues for cancer research and treatment. Buffalo, NY (PRWEB) December 12, 2017 Tumor protein p53 is one of the most critical determinants of the fate of cancer cells, as it can determine whether a cell lives or dies in response to stress. In a new s...

Jennifer Good of Trevi Therapeutics, Vlad Coric of Biohaven Named 2017 CURE Entrepreneurs of the Year

In a ceremony December 12 at the CURE Annual Holiday Party at Alexion in New Haven, the 2017 CURE Entrepreneur of the Year award was presented to Jennifer Good of Trevi Therapeutics and Dr. Vlad Coric of Biohaven Pharmaceuticals, two biotechnology executives whose work has positively affected bioscience in Connecticut and beyond. Jennifer L. Good ...

CRISPR Therapeutics Plans Its First Clinical Trial for Genetic Disease

(Wired) – In the end, Crispr’s leading luminaries formed three companies—Caribou Biosciences, Editas Medicine, and Crispr Therapeutics—to take what they had done in their labs and use it to cure human disease. For nearly five years the “big three’ Crispr … Read More

CURE® Magazine Announces Last Chance to Nominate for the 2018 Extraordinary Healer® Award in Oncology Nursing

Deadline to submit nominations is January 1, 2018 CURE® magazine is once again recognizing top oncology nurses through its Extraordinary Healer® Award. These individuals epitomize exemplary compassion and expertise in patient care. The final day to submit nominations is January 1, 2018. “We are excited to be accepting last chance nominatio...

TetraGenetics Partners with LifeArc to Humanize New Drugs and Perform IND-Enabling Studies

TetraGenetics, a biopharmaceutical company developing novel therapeutics for autoimmune diseases and pain, today announced a partnership with LifeArc®, the UK-based medical research charity. The collaboration brings together the drug discovery skills of TetraGenetics with the antibody humanization and development capabilities of LifeArc. Under the agreeme...

Alternative Viewpoints and Fallacies of Modern Medicine

Robert S. Farmer M.D. authors new book on how to cure many chronic illnesses on your own BALTIMORE (PRWEB) December 12, 2017 Dr. Robert S. Farmer demonstrates that many common, chronic diseases such as obesity and diabetes are usually not genetic and are only rarely viral. Most commonly, they are the result of parasitic infections that virtually all first-world doctors refuse to acknowledge prope...

Faster, more accurate cancer detection using nanoparticles

Using light-emitting nanoparticles, scientists have invented a highly effective method to detect tiny tumors and track their spread, potentially leading to earlier cancer detection and more precise treatment. The technology could improve patient cure rates and survival times.

Unlocking the Puzzle of Neurodegenerative Diseases

Postnova Analytics reports that the Department of Molecular Biology & Biotechnology at the University of Sheffield (UK) is using their AF2000 Field Flow Fractionation system to investigate the mechanism of amyloid formation, a protein mis-folding process implicated to be the cause of Alzheimer’s and other neurodegenerative diseases. Understanding the causes of neurodegenerative diseases ...

Monday 11th December 2017

Dan Haar: It looks like Boston is no cure-all landing spot

A street-level rendering of the planned new headquarters for General Electric in South Boston, which has been delayed by the new CEO as the company runs into problems in its new home. A street-level rendering of the planned new headquarters for General Electric in South Boston, which has been delayed by the new CEO as the company runs into problems in its new home.

Huntington's disease drug clears initial hurdles - raising hopes

Huntington’s disease is a genetic disorder that affects the brain progressively and has no known cure till date. In a breakthrough, the first drug that can target and reduce the cause behind this dreaded disease has been found to be effective, safe and well tolerated in a human clinical trial that was conducted by UCL scientists.

Quick Search

News Quicklinks